| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Epidemiology and Outcomes |

,||,¶
* Divisions of Nephrology;
General Internal Medicine, Department of Medicine,
Health Services Research Enhancement Award Program,
Department of Dermatology, VA Medical Center San Francisco; and || Department of Epidemiology and Biostatistics; and ¶ Department of Medicine, University of California, San Francisco, San Francisco, California
Address correspondence to: Dr. Ann M. OHare, Box 111J, Nephrology, VA Medical Center San Francisco, 4150 Clement Street, San Francisco, CA 94121. Phone: 415-221-4810 ext 4953; Fax: 415-750-6949; E-mail: Ann.O'Hare{at}med.va.gov
Renal insufficiency predicts mortality among patients who are treated for myocardial infarction and congestive heart failure, but its clinical significance in advanced peripheral arterial disease has not been evaluated. A national cohort of 5787 male veterans who received an initial diagnosis of rest pain, ischemic ulceration, or gangrene between January 1, 2000, and September 30, 2002, and had at least one serum creatinine measurement within 3 mo before diagnosis were identified. Sixty-two percent (n = 3561) of cohort members had normal or mildly reduced renal function (GFR
60 ml/min per 1.73 m2), 30% (n = 1742) had moderate renal insufficiency (GFR 30 to 59 ml/min per 1.73 m2), and 8% (n = 484) had severe renal insufficiency or renal failure (GFR <30 ml/min per 1.73 m2) but were not on dialysis. The percentages of patients who presented with gangrene or ischemic ulceration rather than rest pain increased with declining renal function (70, 77, and 87%; P < 0.001), as did 1-yr mortality risk (17, 27, and 44%; P < 0.001). After adjustment for demographic and clinical characteristics, patients with a GFR of 30 to 59 ml/min per 1.73 m2 (odds ratio, 1.32; 95% confidence interval, 1.13 to 1.53) and <30 ml/min per 1.73 m2 (odds ratio, 2.97; 95% confidence interval, 2.39 to 3.69) had a significantly increased odds of death within 1 yr of cohort entry. Both moderate and severe renal insufficiency are associated with an increased odds of death in patients with critical limb ischemia. Death rates were particularly high among those with a GFR <30 ml/min per 1.73 m2. This finding may be partly explained by their more frequent presentation with ischemic ulceration or gangrene rather than rest pain.
Related Article
J. Am. Soc. Nephrol. 2005 16: 279-283.
This article has been cited by other articles:
![]() |
K. I. Paraskevas, N. Bessias, J. Tzorbatzoglou, D. P. Mikhailidis, and V. Andrikopoulos Effect of Statins on Renal Function in Patients With Peripheral Arterial Disease Vascular and Endovascular Surgery, December 1, 2009; 42(6): 620 - 621. [PDF] |
||||
![]() |
Y. Kumada, T. Aoyama, H. Ishii, M. Tanaka, Y. Kawamura, H. Takahashi, T. Toriyama, T. Aoyama, Y. Yuzawa, S. Maruyama, et al. Long-term outcome of percutaneous transluminal angioplasty in chronic haemodialysis patients with peripheral arterial disease Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3996 - 4001. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T Fung, A. M Wilson, F. Zhang, N. Harris, K. A Edwards, J. W Olin, and J. P Cooke A biomarker panel for peripheral arterial disease Vascular Medicine, August 1, 2008; 13(3): 217 - 224. [Abstract] [PDF] |
||||
![]() |
Y. P. Liew, J. R. Bartholomew, S. Demirjian, J. Michaels, and M. J. Schreiber Jr. Combined Effect of Chronic Kidney Disease and Peripheral Arterial Disease on All-Cause Mortality in a High-Risk Population Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1084 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shadman, M. A. Allison, and M. H. Criqui Glomerular Filtration Rate and N-Terminal Pro-Brain Natriuretic Peptide as Predictors of Cardiovascular Mortality in Vascular Patients J. Am. Coll. Cardiol., June 5, 2007; 49(22): 2172 - 2181. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H.H. Feringa, S. E. Karagiannis, M. Chonchol, R. Vidakovic, P. G. Noordzij, A. Elhendy, R. T. van Domburg, G. Welten, O. Schouten, J. J. Bax, et al. Lower Progression Rate of End-Stage Renal Disease in Patients with Peripheral Arterial Disease Using Statins or Angiotensin-Converting Enzyme Inhibitors J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1872 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Guerrero, R. Montes, J. Munoz-Terol, A. Gil-Peralta, J. Toro, M. Naranjo, P. Gonzalez-Perez, C. Martin-Herrera, and A. Ruiz-Fernandez Peripheral arterial disease in patients with stages IV and V chronic renal failure Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3525 - 3531. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-W. Mui, M. Sleeswijk, H. van den Hout, J. van Baal, G. Navis, and A.-J. Woittiez Incidental Renal Artery Stenosis Is an Independent Predictor of Mortality in Patients with Peripheral Vascular Disease J. Am. Soc. Nephrol., July 1, 2006; 17(7): 2069 - 2074. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. O'Hare, D. Bertenthal, A. N. Sidawy, M. G. Shlipak, S. Sen, and M.-M. Chren Renal Insufficiency and Use of Revascularization among a National Cohort of Men with Advanced Lower Extremity Peripheral Arterial Disease Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. O'Hare, A. B. Newman, R. Katz, L. F. Fried, C. O. Stehman-Breen, S. L. Seliger, D. S. Siscovick, and M. G. Shlipak Cystatin C and Incident Peripheral Arterial Disease Events in the Elderly: Results From the Cardiovascular Health Study Arch Intern Med, December 12, 2005; 165(22): 2666 - 2670. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673